Long term trends in prevalence of neural tube defects in Europe: Population based study

BMJ (Online)

Volumn 351, Issue , 2015, Pages

  Khoshnood, Babak ^a   Loane, Maria ^b   De Walle, Hermien ^c   Arriola, Larraitz ^d   Addor, Marie Claude ^e   Barisic, Ingeborg ^f   Beres, Judit ^g   Bianchi, Fabrizio ^h   Dias, Carlos ⁱ   Draper, Elizabeth ^j   Garne, Ester ^k   Gatt, Miriam ^l   Haeusler, Martin ^m   Klungsoyr, Kari ⁿ   Latos Bielenska, Anna ^o   Lynch, Catherine ^p   McDonnell, Bob ^p   Nelen, Vera ^q   Neville, Amanda J ^r   O'Mahony, Mary T ^p   Queisser Luft, Annette ^s   Rankin, Judith ^t   Rissmann, Anke ^u   Ritvanen, Annukka ^v   Rounding, Catherine ^w   Sipek, Antonin ^x   Tucker, David ^y   Verellen Dumoulin, Christine ^z   Wellesley, Diana ^aa   Dolk, Helen ^b   more..

^a PARIS DESCARTES UNIVERSITY   (France)

^b UNIVERSITY OF ULSTER   (United Kingdom)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^e LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^f Croatia   (Croatia)

^g NATIONAL INSTITUTES OF HEALTH   (United States)

^h INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

ⁱ Instituto Nacioanal de Saúde Dr Ricardo Jorge   (Portugal)

^j UNIVERSITY OF LEICESTER   (United Kingdom)

^k KOLDING HOSPITAL   (Denmark)

^l Department of Health Information and Research ^*  (Malta)

^m MEDICAL UNIVERSITY OF GRAZ   (Austria)

ⁿ UNIVERSITY OF BERGEN   (Norway)

^o POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^p HEALTH SERVICE EXECUTIVE   (Ireland)

^q Provincial Institute for Hygiene   (Belgium)

^r UNIVERSITY OF FERRARA   (Italy)

^s JOHANNES GUTENBERG UNIVERSITY   (Germany)

^t NEWCASTLE UNIVERSITY   (United Kingdom)

^u OTTO VON GUERICKE UNIVERSITY   (Germany)

^v NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^w UNIVERSITY OF OXFORD   (United Kingdom)

^x FAKULTNÍ THOMAYEROVA NEMOCNICE   (Czech Republic)

^y PUBLIC HEALTH WALES   (United Kingdom)

^z Department of Pathology   (Belgium)

^aa UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANENCEPHALUS; ARTICLE; CONTROLLED STUDY; EUROPE; HUMAN; LIVE BIRTH; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; POISSON DISTRIBUTION; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; REGISTER; SPINAL DYSRAPHISM; TREND STUDY; ABORTION; DIETARY SUPPLEMENT; FEMALE; FETUS DEATH; FOOD ASSISTANCE; MANAGEMENT; NEEDS ASSESSMENT; NEURAL TUBE DEFECTS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; STATISTICS AND NUMERICAL DATA;

FOLIC ACID; VITAMIN B COMPLEX;

ABORTION, EUGENIC; DIETARY SUPPLEMENTS; EUROPE; FEMALE; FETAL DEATH; FOLIC ACID; FOOD ASSISTANCE; HUMANS; LIVE BIRTH; NEEDS ASSESSMENT; NEURAL TUBE DEFECTS; POLICY MAKING; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREVALENCE; VITAMIN B COMPLEX;

EID: 84952673713     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.h5949     Document Type: Article

References (27)

1. Botto LD, Moore CA, Khoury MJ, Erickson JD. Neural-tube defects. N Engl J Med 1999;341:1509-19.
2. Dunlap B, Shelke K, Salem SA, Keith LG. Folic acid and human reproduction-ten important issues for clinicians. J Exp Clin Assist Reprod 2011;8:2.
3. Garne E, Loane M, Dolk H, et al. Prenatal diagnosis of severe structural congenital malformations in Europe. Ultrasound Obstet Gynecol 2005;25:6-11.
4. Boyd PA, Devigan C, Khoshnood B, Loane M, Garne E, Dolk H. Survey of prenatal screening policies in Europe for structural malformations and chromosome anomalies, and their impact on detection and termination rates for neural tube defects and Down's syndrome. BJOG 2008;115:689-96.
5. Khoshnood B, Greenlees R, Loane M, Dolk H. Paper 2: EUROCAT public health indicators for congenital anomalies in Europe. Birth Defects Res A Clin Mol Teratol 2011;91(suppl 1):S16-22.
6. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991;338:131-7.
7. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832-5.
8. Oakley GP Jr. The scientific basis for eliminating folic acid-preventable spina bifida: a modern miracle from epidemiology. Ann Epidemiol 2009;19:226-30.
9. EUROCAT Folic Acid Working Group. EUROCAT special report: prevention of neural tube defects by folic acid supplementation in Europe. 2009. www.eurocat-network.eu/content/Special-Report-NTD-3rdEd-Part-I.pdf.
10. Busby A, Abramsky L, Dolk H, Armstrong B. Preventing neural tube defects in Europe: population based study. BMJ 2005;330:574-5.
11. Bestwick JP, Huttly WJ, Morris JK, Wald NJ. Prevention of neural tube defects: a cross-sectional study of the uptake of folic acid supplementation in nearly half a million women. PLoS One 2014;9:e89354.
12. Tort J, Lelong N, Prunet C, Khoshnood B, Blondel B. Maternal and health care determinants of preconceptional use of folic acid supplementation in France: results from the 2010 National Perinatal Survey. BJOG 2013;120:1661-7.
13. Greenlees R, Neville A, Addor MC, et al. Paper 6: EUROCAT member registries: organization and activities. Birth Defects Res A Clin Mol Teratol 2011;91(suppl 1):S51-100.
14. Royston P. A strategy for modelling the effect of a continuous covariate in medicine and epidemiology. Stat Med 2000;19:1831-47.
15. Sauerbrei W, Royston P, Binder H. Selection of important variables and determination of functional form for continuous predictors in multivariable model building. Stat Med 2007;26:5512-28.
16. Rankin J, Pattenden S, Abramsky L, et al. Prevalence of congenital anomalies in five British regions, 1991-99. Arch Dis Child Fetal Neonatal Ed 2005;90:F374-9.
17. Loane M, Dolk H, Garne E, Greenlees R, EUROCAT Working Group. Paper 3: EUROCAT data quality indicators for population-based registries of congenital anomalies. Birth Defects Res A Clin Mol Teratol 2011;91(suppl 1):S23-30.
18. Hoey L, McNulty H, Askin N, et al. Effect of a voluntary food fortification policy on folate, related B vitamin status, and homocysteine in health adults. Am J Clin Nutr 2007;86:1405-13.
19. Flynn MA, Anderson WA, Burke SJ, Reilly A. Session 1: Public health nutrition. Folic acid food fortification: the Irish experience. Proc Nutr Soc 2008;67:381-9.
20. Hackshaw A, Rodeck C, Boniface S. Maternal smoking in pregnancy and birth defects: a systematic review based on 173 687 malformed cases and 11.7 million controls. Hum Reprod Update 2011;17:589-604.
21. Mladovsky P, Allin S, Masseria C, Hernandez-Quevedo, McDaid D, Mossialos E. Health in the European Union: trends and analysis. World Health Organization, 2009:76-81 (Observaotry Studies Series No 19).
22. Lelong N, Blondel B, Kaminski M. [Smoking during pregnancy in France between 1972 to 2003: results from the national perinatal surveys]. J Gynecol Obstet Biol Reprod (Paris) 2011;40:42-9.
23. Jentink J, Bakker MK, Nijenhuis CM, Wilffert B, De Jong-Van Den Berg LT. Does folic acid use decrease the risk for spina bifida after in utero exposure to valproic acid? sPharmacoepidemiol Drug Saf 2010;19:803-7.
24. Jentink J, Loane MA, Dolk H, et al. Valproic acid monotherapy in pregnancy and major congenital malformations. N Engl J Med 2010;362:2185-93.
25. Jentink J, Dolk H, Loane MA, et al. Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study. BMJ 2010;341:c6581.
26. Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LY. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 2001;285:2981-6.
27. Oakley GP, Mandel JS. Folic acid fortification remains an urgent health priority. BMJ 2004;329:1376.